Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of ...

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...

Investigators analyzed economic evaluations of adjuvant immunotherapy to assess cost-effectiveness outcomes, quality-adjusted life-year (QALY)/life-year (LY) gains, and methodologic approaches.

A curious phenomenon seen by oncologists, that morning patients do better than those receiving afternoon infusions, gains ...

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

For patients diagnosed with stage 4 cancer, a condition often accompanied by limited treatment options and grim prognoses, immunotherapy offers a new ray of hope. This groundbreaking approach utilizes ...

A combination immunotherapy approach using Ampligen (rintatolimod) and Imfinzi (durvalumab) showed clinical activity for ...

Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research ...

Researchers are testing whether fecal microbiota transplants can reduce side effects and boost cancer treatment response.

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

Long-term clinical trials show patients with stage four kidney cancer are living a decade or more beyond previous ...

Immunotherapy is a cancer treatment that harnesses the body’s immune system to fight cancer. It helps the immune system recognize and attack cancer cells, which can sometimes be hidden from the body’s ...